GlassScriptPhysician profile
Aaqib H Malik
NPI 1053629956
$1,474.40
in general payments reported to CMS, 2019-2025
15 companies · $67.01 in 2025
The $67.01 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.53 · 2020: $25.02 · 2021: $434 · 2022: $621 · 2023: $183 · 2024: $130 · 2025: $67.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $225 · Food and Beverage: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $224.59 |
| Food and Beverage | $155.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $362.48 | 2021-2022 | |
| Astellas Pharma US INC | $353.98 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $143.22 | 2021-2023 | Lifevest |
| Chiesi USA, INC. | $108.97 | 2022 | |
| Abiomed | $93.29 | 2023-2025 | Impella |
| Janssen Pharmaceuticals, INC | $77.22 | 2020-2021 | |
| Medtronic, INC. | $73.88 | 2023 | Onyx Frontier |
| Shockwave Medical, INC | $69.96 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Alnylam Pharmaceuticals INC. | $47.87 | 2025 | Amvuttra |
| Boston Scientific Corporation | $36.69 | 2022 | |
| Lantheus Medical Imaging, INC. | $28.71 | 2022 | |
| Pfizer INC. | $25.02 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $24.06 | 2022 | |
| Portola Pharmaceuticals, LLC | $14.53 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.52 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaqib Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.